hs-CRP, IL-6,

V-CAM, I-
CAM, MMP-9,
202 STEMI E-selectin,
patients with lipid profile, LGE-CMR Mortality
pPCI NT-proBNP hs-CRP pattern assessment

Day 1 Day 5 1-month 2-years

 2-year follow-
up

1.5 T
LGE-CMR
• Day 1: hs-CRP, IL-6, • Impact of
V-CAM, I-CAM,
MMP-9, E-selectin, • Myocardial scar inflammation
lipids, • IS, transmurality and
• NT-proBNP • myocardial
LV volumes
• Day 5: hs-CRP
function scar
202 STEMI patients Mortality
Mortality
with pPCI assessment

1-month follow-
up
 ACUTE PHASE 1 MONTH FOLLOW-UP 2 YEAR FOLLOW-UP

Acute inflammatory response

Hs-CRP, IL-
6, V-CAM,
I-CAM,
MMP-9, E-
selectin,
202 STEMI Lipids, Hs-CRP
1.5 T MORTALITY
patients pPCI
NT-proBNP LGE-CMR ASSESSMENT

Day 1 Day 5

Myocardial scar Cardiac functions

Infarct Size High transmurality LV Volumes LVEF

Cardiac index

CMR INJURY BIOMARKERS